Henrique D Teixeira

Jul 24, 2024 | jamanetwork.com | Andrew Blauvelt |Henrique D Teixeira |Eric Simpson |Antonio Costanzo

Error in Table Footnote Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Andrew Blauvelt, MD, MBA; Henrique D. Teixeira, PhD, MBA; Eric L. Simpson, MD, MCR; Antonio Costanzo, MD; Marjolein De Bruin-Weller, MD; Sebastien Barbarot, MD, PhD; Vimal H. Prajapati, MD; Peter Lio, MD; Xiaofei Hu, PhD; Tianshuang Wu, PhD; John Liu, MD, MS; Barry Ladizinski, MD, MPH, MBA; Alvina D.

Feb 14, 2024 | jamanetwork.com | Andrew Blauvelt |Henrique D Teixeira |Eric Simpson |Antonio Costanzo

Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Andrew Blauvelt, MD, MBA; Henrique D. Teixeira, PhD, MBA; Eric L. Simpson, MD, MCR; Antonio Costanzo, MD; Marjolein De Bruin-Weller, MD; Sebastien Barbarot, MD, PhD; Vimal H.